Pain. 2016 Jan 05. doi: 10.1097/j.pain.0000000000000486. [Epub ahead of print]

Primary somatosensory/motor cortical thickness distinguishes paresthesia- from pain-dominant carpal tunnel syndrome

Maeda Y, Kettner N, Kim J, Kim H, Cina S, Malatesta C, Gerber J, McManus C, Libby A, Mezzacappa P, Mawla I, Morse LR, Audette J, Napadow V.

Abstract

Paresthesia-and pain-dominant subgroups have been noted in carpal tunnel syndrome (CTS), a peripheral neuropathic disorder characterized by altered primary somatosensory/motor (S1/M1) physiology. We aimed to investigate whether brain morphometry dissociates these subgroups. CTS subjects were evaluated with nerve conduction studies, while symptom severity ratings were used to allocate subjects into paresthesia-dominant (CTS-paresthesia), pain-dominant (CTS-pain), and pain/paresthesia non-dominant (not included in further analysis) subgroups. Structural brain MRI data were acquired at 3T using a multi-echo MPRAGE T1-weighted pulse sequence, and gray matter cortical thickness was calculated across the entire brain using validated, automated methods. CTS-paresthesia subjects demonstrated reduced median sensory nerve conduction velocity (p=0.05) compared to CTS-pain. In addition, cortical thickness in pre- and post-central gyrus (S1/M1 hand area) contralateral to the more affected hand was significantly reduced in CTS-paresthesia compared to CTS-pain. Moreover, in CTS-paresthesia subjects, pre-central cortical thickness was negatively correlated with paresthesia severity (r(34)=-0.40, p=0.016) and positively correlated with median nerve sensory velocity (r(36)=0.51, p=0.001), but not with pain severity. Conversely, in CTS-pain subjects, contralesional S1 (r(9)=0.62, p=0.042) and M1 (r(9)=0.61, p=0.046) cortical thickness was correlated with pain severity, but not median nerve velocity or paresthesia severity. This double dissociation in somatotopically-specific S1/M1 areas suggests a neuroanatomical substrate for symptom-based CTS subgroups. Such fine-grained subgrouping of CTS may lead to improved personalized therapeutic approaches, based on superior characterization of the linkage between peripheral and central neuroplasticity.

PMID: 26761384